Amoxicillin 1 g Three Times Daily for 5–7 Days: Evidence-Based Prescribing
For an adult with normal renal function, no penicillin allergy, and not pregnant, prescribe amoxicillin 1 g orally three times daily for 7 days for acute bacterial rhinosinusitis or lower respiratory tract infections, as this regimen is supported by multiple randomized controlled trials and guideline evidence. 1
Dosing Regimen
Administer amoxicillin 1 g (1000 mg) orally three times daily, with doses spaced approximately 8 hours apart. 1
The standard treatment duration is 7 days for acute bacterial rhinosinusitis, which is as effective as 10-day courses while reducing adverse events. 2
For uncomplicated lower respiratory tract infections, 7 days of treatment is appropriate and supported by clinical trial data. 1
Clinical Context and Indications
This dosing regimen (amoxicillin 1 g three times daily) has been validated in multiple double-blind placebo-controlled trials for acute post-viral rhinosinusitis in adults with purulent secretions, facial pain, and symptoms lasting 7–28 days. 1
The European Position Paper on Rhinosinusitis (2020) includes studies using amoxicillin 750 mg three times daily for 7 days and 1 g twice daily for 10 days, demonstrating efficacy in radiologically confirmed maxillary sinusitis. 1
For lower respiratory tract infections, amoxicillin 1 g three times daily for 7 days showed no clinically meaningful benefit over placebo in unselected primary care patients, but may reduce illness deterioration in patients with combined bacterial-viral infections. 3
Administration Instructions
Amoxicillin may be taken with or without food; absorption is not significantly affected by meals. 4
Ensure adequate hydration during treatment to minimize gastrointestinal side effects. 4
Complete the full 7-day course even if symptoms improve earlier, to prevent treatment failure and reduce resistance development. 2
When to Consider Higher Doses
If the patient has risk factors for antimicrobial resistance—including antibiotic use within the past month, healthcare exposure, smoking, age >65 years, diabetes, or chronic cardiopulmonary disease—consider escalating to amoxicillin-clavulanate 2000 mg/125 mg twice daily instead of amoxicillin alone. 2
In communities with >10% prevalence of penicillin-resistant Streptococcus pneumoniae, higher-dose amoxicillin-clavulanate (2000 mg/125 mg twice daily) achieves 90–92% predicted clinical efficacy versus 83–88% for standard dosing. 2
Monitoring and Follow-Up
Reassess clinical response within 48–72 hours of initiating therapy; if symptoms worsen or fail to improve, consider alternative pathogens, resistance, or complications. 2
Advise patients to return immediately if they develop severe headache, visual changes, neck stiffness, or high fever, which may indicate intracranial complications. 1
Common Pitfalls and Caveats
Amoxicillin monotherapy (without clavulanate) is appropriate only when beta-lactamase-producing organisms are unlikely; for suspected Haemophilus influenzae or Moraxella catarrhalis, amoxicillin-clavulanate is preferred. 2
Gastrointestinal adverse events (diarrhea, nausea, abdominal pain) occur in 15–40% of patients but rarely require discontinuation. 2
Do not prescribe amoxicillin for viral upper respiratory infections or uncomplicated acute bronchitis, as antibiotics provide no benefit and increase resistance. 3
In patients with mononucleosis, amoxicillin frequently causes a characteristic maculopapular rash (not a true allergy); avoid amoxicillin if infectious mononucleosis is suspected. 4
Renal Dosing Adjustments
No dose adjustment is required for creatinine clearance ≥30 mL/min. 4
For creatinine clearance 10–30 mL/min, reduce frequency to 1 g every 12 hours. 4
For creatinine clearance <10 mL/min, reduce frequency to 1 g every 24 hours. 4
Patients on hemodialysis require a supplemental 1 g dose after each dialysis session. 4
Alternative Regimens
Amoxicillin 1 g twice daily for 10 days has been studied in acute sinusitis and showed comparable efficacy to three-times-daily dosing, potentially improving adherence. 1
For patients unable to tolerate amoxicillin or with documented penicillin allergy, doxycycline 100 mg twice daily or a respiratory fluoroquinolone may be considered, though fluoroquinolones should be reserved for patients with significant comorbidities or treatment failure. 2